Study Risk of Hepatic Encephalopathy in Diabetic Patients with Decompensated Cirrhosis

ABEER A. SHAHBA, M.D., KHALED M. DARWISH, M.D.;; MARIAM N. EL-MAHALAWY, M.Sc., AMAL A. SELIM, M.D.;

doi:10.21608/mjcu.2018.55213

Study Risk of Hepatic Encephalopathy in Diabetic Patients with Decompensated Cirrhosis

Document Type : Original Article

Authors

The Department of Internal Medicine, Faculty of Medicine, Tanta University

10.21608/mjcu.2018.55213

Abstract

Abstract
Background: Hepatic Encephalopathy (HE) is a serious complication in patients with cirrhotic liver disease. Diabetic patients with decompensated cirrhosis are suffering more than non-diabetic patients.
Patients and Methods: This study included 100 patients with decompensated cirrhosis and they were classified into 2 main groups:
Group (A): Diabetic with decompensated cirrhosis. They were further classified into diabetic patients and patients with Impaired Glucose Tolerance (IGT).
Group (B): Non-diabetic with decompensated cirrhosis.
Then we compared the risk of hepatic encephalopathy between the 2 groups.
Results: Diabetic patients are at higher risk for HE than patients with IGT and both are at higher risk than non-diabetic patients.
Conclusion: Patients with cirrhosis should be screened for IGT and diabetes at frequent intervals so that early inter-vention can be initiated when required.

Keywords